Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift

In humans, low serum carnosinase (CN1) activity protects patients with type 2 diabetes from diabetic nephropathy. We now characterized the interaction of thiol-containing compounds with CN1 cysteine residue at position 102, which is important for CN1 activity. Reduced glutathione (GSH), N-acetylcyst...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Enzyme Inhib Med Chem
Autors principals: Peters, Verena, Schmitt, Claus P., Weigand, Tim, Klingbeil, Kristina, Thiel, Christian, van den Berg, Antje, Calabrese, Vittorio, Nawroth, Peter, Fleming, Thomas, Forsberg, Elisabete, Wagner, Andreas H., Hecker, Markus, Vistoli, Giulio
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6009930/
https://ncbi.nlm.nih.gov/pubmed/28776438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2017.1355793
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars